|
Orthologous residues
|
|
BLM (human): T122‑p, BLM (mouse): T122‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
flow cytometry, mutation of modification site, western blotting
|
|
Relevant cell lines - cell types - tissues:
GM9607 (fibroblast), PSNF5 (fibroblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Downstream Regulation
|
|
Effect of modification (process):
cell cycle regulation
|
|
Comments:
In cells expressing BLM T99A/T122A after HU release, entrance into G1 phase was delayed, with p-Chk-1 levels remaining elevated.
|